Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0D1LS
|
|||
Former ID |
DIB009205
|
|||
Drug Name |
5-Fluoro-2-deoxycytidine
|
|||
Synonyms |
FdCyd; 5-Fluoro-2'-deoxycytidine
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C00-D48; ICD-9: 140-199, 210-229] | Phase 2 | [1] | |
Company |
City of Hope
|
|||
Structure |
Download2D MOL |
|||
Formula |
C9H12FN3O4
|
|||
Canonical SMILES |
C1C(C(OC1N2C=C(C(=NC2=O)N)F)CO)O
|
|||
InChI |
1S/C9H12FN3O4/c10-4-2-13(9(16)12-8(4)11)7-1-5(15)6(3-14)17-7/h2,5-7,14-15H,1,3H2,(H2,11,12,16)/t5-,6+,7+/m0/s1
|
|||
InChIKey |
IDYKCXHJJGMAEV-RRKCRQDMSA-N
|
|||
CAS Number |
CAS 10356-76-0
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | ClinicalTrials.gov (NCT00978250) A Multi-Histology Phase II Study of 5-Fluoro-2-Deoxycytidine With Tetrahydrouridine (FdCyd + THU). U.S. National Institutes of Health. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.